Area of research
Radiology, Nuclear Medicine and Imaging · Hepatology
Research interest
Research interests include MRI in cancer diagnosis, Hepatocellular Carcinoma Treatment and Prognosis, Radiomics and Machine Learning in Medical Imaging, and Advanced X-ray and CT Imaging.
Automated radiomics model for prediction of therapy response and minimal residual disease from baseline MRI in multiple myeloma
The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma
The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma.
NUT Carcinoma—An Underdiagnosed Malignancy
Image Quality and Radiation Dose of Contrast-Enhanced Chest-CT Acquired on a Clinical Photon-Counting Detector CT vs. Second-Generation Dual-Source CT in an Oncologic Cohort: Preliminary Results
Deep Learning for Automatic Bone Marrow Apparent Diffusion Coefficient Measurements From Whole-Body Magnetic Resonance Imaging in Patients With Multiple Myeloma
Case report: Immunovirotherapy as a novel add-on treatment in a patient with thoracic NUT carcinoma
Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancer
Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinoma
Long‐term remission of small cell lung cancer after reactivation of tuberculosis following immune‐checkpoint blockade: A case report
Intraprocedural cone-beam CT with parenchymal blood volume assessment for transarterial chemoembolization guidance: Impact on the effectiveness of the individual TACE sessions compared to DSA guidance alone
Transbronchial cryobiopsy increases diagnostic confidence in interstitial lung disease: a prospective multicentre trial
Transbronchial cryobiopsy increases diagnostic confidence in interstitial lung disease: a prospective multicentre trial.
Next-Generation Sequencing of Advanced GI Tumors Reveals Individual Treatment Options
Hybrid Modelling of Transarterial Chemoembolisation Therapies (TACE) for Hepatocellular Carcinoma (HCC)
Intermetatarsal bursitis as first disease manifestation in different rheumatological disorders and related MR-imaging findings.
Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma – The SHELTER study
Whole-Body Reduced-Dose CT As Primary Staging and during Follow-up in First-Line Treatment of Transplant-Eligible Multiple Myeloma Patients: Results of the German GMMG-MM5 Trial